PMC:7200337 / 45605-46163
Annnotations
LitCovid-PD-FMA-UBERON
| Id | Subject | Object | Predicate | Lexical cue | fma_id |
|---|---|---|---|---|---|
| T451 | 9-17 | Body_part | denotes | Antibody | http://purl.org/sig/ont/fma/fma62871 |
| T452 | 65-68 | Body_part | denotes | IgM | http://purl.org/sig/ont/fma/fma62873 |
| T453 | 73-76 | Body_part | denotes | IgG | http://purl.org/sig/ont/fma/fma62872 |
| T454 | 95-100 | Body_part | denotes | serum | http://purl.org/sig/ont/fma/fma63083 |
| T455 | 158-161 | Body_part | denotes | RNA | http://purl.org/sig/ont/fma/fma67095 |
| T456 | 204-212 | Body_part | denotes | antibody | http://purl.org/sig/ont/fma/fma62871 |
| T457 | 308-316 | Body_part | denotes | antibody | http://purl.org/sig/ont/fma/fma62871 |
| T458 | 442-447 | Body_part | denotes | cells | http://purl.org/sig/ont/fma/fma68646 |
LitCovid-PD-UBERON
| Id | Subject | Object | Predicate | Lexical cue | uberon_id |
|---|---|---|---|---|---|
| T50 | 95-100 | Body_part | denotes | serum | http://purl.obolibrary.org/obo/UBERON_0001977 |
LitCovid-PD-MONDO
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T289 | 39-47 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
| T290 | 374-382 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
| T291 | 504-512 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
| T292 | 548-557 | Disease | denotes | infection | http://purl.obolibrary.org/obo/MONDO_0005550 |
LitCovid-PD-CLO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T576 | 50-55 | http://purl.obolibrary.org/obo/NCBITaxon_10239 | denotes | Virus |
| T577 | 440-447 | http://purl.obolibrary.org/obo/CL_0000236 | denotes | B cells |
LitCovid-PD-GO-BP
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T144 | 433-439 | http://purl.obolibrary.org/obo/GO_0007613 | denotes | memory |
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 1476 | 346-348 | Gene | denotes | to | Gene:6999 |
| 1477 | 272-280 | Species | denotes | patients | Tax:9606 |
| 1478 | 374-382 | Species | denotes | SARS-CoV | Tax:694009 |
| 1479 | 504-514 | Species | denotes | SARS-CoV-2 | Tax:2697049 |
| 1480 | 257-271 | Disease | denotes | critically ill | MESH:D016638 |
| 1481 | 548-557 | Disease | denotes | infection | MESH:D007239 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T245 | 0-49 | Sentence | denotes | Figure 4 Antibody-Mediated Immunity in SARS-CoV-2 |
| T246 | 50-151 | Sentence | denotes | Virus-specific IgM and IgG are detectable in serum between 7 and 14 days after the onset of symptoms. |
| T247 | 152-220 | Sentence | denotes | Viral RNA is inversely correlated with neutralizing antibody titers. |
| T248 | 221-369 | Sentence | denotes | Higher titers have been observed in critically ill patients, but it is unknown whether antibody responses somehow contribute to pulmonary pathology. |
| T249 | 370-558 | Sentence | denotes | The SARS-CoV-1 humoral response is relatively short lived, and memory B cells may disappear altogether, suggesting that immunity with SARS-CoV-2 may wane 1–2 years after primary infection. |